Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment Response.

IF 2.8 Q2 ONCOLOGY JCO Clinical Cancer Informatics Pub Date : 2025-01-01 Epub Date: 2025-01-22 DOI:10.1200/CCI.24.00042
Raul F Valenzuela, Elvis de Jesus Duran Sierra, Mathew A Canjirathinkal, Behrang Amini, Ken-Pin Hwang, Jingfei Ma, Keila E Torres, R Jason Stafford, Wei-Lien Wang, Robert S Benjamin, Andrew J Bishop, John E Madewell, William A Murphy, Colleen M Costelloe
{"title":"Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment Response.","authors":"Raul F Valenzuela, Elvis de Jesus Duran Sierra, Mathew A Canjirathinkal, Behrang Amini, Ken-Pin Hwang, Jingfei Ma, Keila E Torres, R Jason Stafford, Wei-Lien Wang, Robert S Benjamin, Andrew J Bishop, John E Madewell, William A Murphy, Colleen M Costelloe","doi":"10.1200/CCI.24.00042","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Undifferentiated pleomorphic sarcomas (UPSs) demonstrate therapy-induced hemosiderin deposition, granulation tissue formation, fibrosis, and calcification. We aimed to determine the treatment-assessment value of morphologic tumoral hemorrhage patterns and first- and high-order radiomic features extracted from contrast-enhanced susceptibility-weighted imaging (CE-SWI).</p><p><strong>Materials and methods: </strong>This retrospective institutional review board-authorized study included 33 patients with extremity UPS with magnetic resonance imaging and resection performed from February 2021 to May 2023. Volumetric tumor segmentation was obtained at baseline, postsystemic chemotherapy (PC), and postradiation therapy (PRT). The pathology-assessed treatment effect (PATE) in surgical specimens separated patients into responders (R; ≥90%, n = 16), partial responders (PR; 89%-31%, n = 10), and nonresponders (NR; ≤30%, n = 7). RECIST, WHO, and volume were assessed for all time points. CE-SWI T2* morphologic patterns and 107 radiomic features were analyzed.</p><p><strong>Results: </strong>A Complete-Ring (CR) pattern was observed in PRT in 71.4% of R (<i>P</i> = 7.71 × 10<sup>-6</sup>), an Incomplete-Ring pattern in 33.3% of PR (<i>P</i> = .2751), and a Globular pattern in 50% of NR (<i>P</i> = .1562). The first-order radiomic analysis from the CE-SWI intensity histogram outlined the values of the 10th and 90th percentiles and their skewness. R showed a 280% increase in 10th percentile voxels (<i>P</i> = .061) and a 241% increase in skewness (<i>P</i> = .0449) at PC. PR/NR showed a 690% increase in the 90th percentile voxels (<i>P</i> = .03) at PC. Multiple high-order radiomic texture features observed at PRT discriminated better R versus PR/NR than the first-order features.</p><p><strong>Conclusion: </strong>CE-SWI morphologic patterns strongly correlate with PATE. The CR morphology pattern was the most frequent in R and had the highest statistical association predicting response at PRT, easily recognized by a radiologist not requiring postprocessing software. It can potentially outperform size-based metrics, such as RECIST. The first- and high-order radiomic analysis found several features separating R versus PR/NR.</p>","PeriodicalId":51626,"journal":{"name":"JCO Clinical Cancer Informatics","volume":"9 ","pages":"e2400042"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO Clinical Cancer Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1200/CCI.24.00042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/22 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Undifferentiated pleomorphic sarcomas (UPSs) demonstrate therapy-induced hemosiderin deposition, granulation tissue formation, fibrosis, and calcification. We aimed to determine the treatment-assessment value of morphologic tumoral hemorrhage patterns and first- and high-order radiomic features extracted from contrast-enhanced susceptibility-weighted imaging (CE-SWI).

Materials and methods: This retrospective institutional review board-authorized study included 33 patients with extremity UPS with magnetic resonance imaging and resection performed from February 2021 to May 2023. Volumetric tumor segmentation was obtained at baseline, postsystemic chemotherapy (PC), and postradiation therapy (PRT). The pathology-assessed treatment effect (PATE) in surgical specimens separated patients into responders (R; ≥90%, n = 16), partial responders (PR; 89%-31%, n = 10), and nonresponders (NR; ≤30%, n = 7). RECIST, WHO, and volume were assessed for all time points. CE-SWI T2* morphologic patterns and 107 radiomic features were analyzed.

Results: A Complete-Ring (CR) pattern was observed in PRT in 71.4% of R (P = 7.71 × 10-6), an Incomplete-Ring pattern in 33.3% of PR (P = .2751), and a Globular pattern in 50% of NR (P = .1562). The first-order radiomic analysis from the CE-SWI intensity histogram outlined the values of the 10th and 90th percentiles and their skewness. R showed a 280% increase in 10th percentile voxels (P = .061) and a 241% increase in skewness (P = .0449) at PC. PR/NR showed a 690% increase in the 90th percentile voxels (P = .03) at PC. Multiple high-order radiomic texture features observed at PRT discriminated better R versus PR/NR than the first-order features.

Conclusion: CE-SWI morphologic patterns strongly correlate with PATE. The CR morphology pattern was the most frequent in R and had the highest statistical association predicting response at PRT, easily recognized by a radiologist not requiring postprocessing software. It can potentially outperform size-based metrics, such as RECIST. The first- and high-order radiomic analysis found several features separating R versus PR/NR.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对比增强敏感性加权成像形态学和放射学特征在预测四肢软组织未分化多形性肉瘤治疗反应中的新用途和价值。
目的:未分化多形性肉瘤(ups)表现出治疗诱导的含铁血黄素沉积、肉芽组织形成、纤维化和钙化。我们的目的是确定从对比增强敏感性加权成像(CE-SWI)中提取的形态学肿瘤出血模式和一阶和高阶放射学特征的治疗评估价值。材料和方法:这项回顾性机构审查委员会授权的研究纳入了33例肢体UPS患者,于2021年2月至2023年5月进行了磁共振成像和切除术。在基线、全身化疗后(PC)和放疗后治疗(PRT)时获得体积肿瘤分割。手术标本病理评估治疗效果(PATE)将患者分为反应者(R;≥90%,n = 16),部分缓解者(PR;89%-31%, n = 10)和无反应(NR;≤30%,n = 7)。评估所有时间点的RECIST、WHO和体积。分析CE-SWI T2*形态和107个放射学特征。结果:71.4%的R患者PRT为Complete-Ring (P = 7.71 × 10-6)型,33.3%的PR患者为Incomplete-Ring (P = 0.2751)型,50%的NR患者为Globular (P = 0.1562)型。CE-SWI强度直方图的一阶放射学分析概述了第10和第90百分位的值及其偏度。R显示PC的第10百分位体素增加280% (P = 0.061),偏度增加241% (P = 0.0449)。PR/NR显示PC组第90百分位体素增加690% (P = 0.03)。在PRT上观察到的多个高阶放射性纹理特征比一阶特征更能区分R与PR/NR。结论:CE-SWI形态模式与PATE密切相关。CR形态学模式在R中最常见,并且在预测PRT反应方面具有最高的统计相关性,不需要后处理软件,放射科医生很容易识别。它可以潜在地优于基于大小的度量,例如RECIST。一级和高阶放射学分析发现了几个区分R与PR/NR的特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.20
自引率
4.80%
发文量
190
期刊最新文献
Self-Supervised Transformer-Based Pipeline for Liver Tumor Segmentation and Type Classification. Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration. Validation of Claims-Based Algorithms to Classify Thoracic Radiation Therapy Courses. Evaluating the Readiness of Saudi Oncology Real-World Data for Standardization and Quality Enhancement. Exploring the Past and Current Landscape of Biomarker-Driven Clinical Trials Through Large Language Models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1